Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease (Q40600194)

From Wikidata
Jump to navigation Jump to search
scientific article published on July 2001
edit
Language Label Description Also known as
English
Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease
scientific article published on July 2001

    Statements

    Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease (English)
    C M Eng
    N Guffon
    W R Wilcox
    D P Germain
    S Waldek
    L Caplan
    G E Linthorst
    International Collaborative Fabry Disease Study Group
    1 July 2001
    9-16

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit